BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bukhari SI, Imam SS, Ahmad MZ, Vuddanda PR, Alshehri S, Mahdi WA, Ahmad J. Recent Progress in Lipid Nanoparticles for Cancer Theranostics: Opportunity and Challenges. Pharmaceutics 2021;13:840. [PMID: 34200251 DOI: 10.3390/pharmaceutics13060840] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Marques AC, Costa PC, Velho S, Amaral MH. Lipid Nanoparticles Functionalized with Antibodies for Anticancer Drug Therapy. Pharmaceutics 2023;15. [PMID: 36678845 DOI: 10.3390/pharmaceutics15010216] [Reference Citation Analysis]
2 Guzmán Rodríguez A, Sablón Carrazana M, Rodríguez Tanty C, Malessy MJA, Fuentes G, Cruz LJ. Smart Polymeric Micelles for Anticancer Hydrophobic Drugs. Cancers (Basel) 2022;15. [PMID: 36612002 DOI: 10.3390/cancers15010004] [Reference Citation Analysis]
3 Agnihotri TG, Gomte SS, Jain A. Emerging theranostics to combat cancer: a perspective on metal-based nanomaterials. Drug Dev Ind Pharm 2022;48:585-601. [PMID: 36448770 DOI: 10.1080/03639045.2022.2153862] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Jiang Z, Zhang W, Zhang J, Liu T, Xing J, Zhang H, Tang D. Nanomaterial-Based Drug Delivery Systems: A New Weapon for Cancer Immunotherapy. Int J Nanomedicine 2022;17:4677-96. [PMID: 36211025 DOI: 10.2147/IJN.S376216] [Reference Citation Analysis]
5 Pallavi P, Harini K, Anand Arumugam V, Gowtham P, Girigoswami K, Muthukrishnan S, Girigoswami A. Nanoformulation of Tetrapyrroles Derivatives in Photodynamic Therapy: A Focus on Bacteriochlorin. Evid Based Complement Alternat Med 2022;2022:3011918. [PMID: 36212948 DOI: 10.1155/2022/3011918] [Reference Citation Analysis]
6 Ali AA, Al-Othman A, Al-Sayah M. Multifunctional stimuli-responsive hybrid nanogels for cancer therapy: Current status and challenges. J Control Release 2022:S0168-3659(22)00628-9. [PMID: 36170926 DOI: 10.1016/j.jconrel.2022.09.033] [Reference Citation Analysis]
7 Dessale M, Mengistu G, Mengist HM. Nanotechnology: A Promising Approach for Cancer Diagnosis, Therapeutics and Theragnosis. Int J Nanomedicine 2022;17:3735-49. [PMID: 36051353 DOI: 10.2147/IJN.S378074] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Yan H, Zhai B, Yang F, Chen Z, Zhou Q, Paiva-Santos AC, Yuan Z, Zhou Y. Nanotechnology-Based Diagnostic and Therapeutic Strategies for Neuroblastoma. Front Pharmacol 2022;13:908713. [PMID: 35721107 DOI: 10.3389/fphar.2022.908713] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhao Y, Li L, Zhou E, Wang J, Wang Y, Guo L, Zhang X. Lipid-Based Nanocarrier Systems for Drug Delivery: Advances and Applications. Pharmaceutical Fronts 2022;04:e43-e60. [DOI: 10.1055/s-0042-1751036] [Reference Citation Analysis]
10 Rustad EAL, von Hofsten S, Kumar R, Lænsman EA, Berge G, Škalko-basnet N. The pH-Responsive Liposomes—The Effect of PEGylation on Release Kinetics and Cellular Uptake in Glioblastoma Cells. Pharmaceutics 2022;14:1125. [DOI: 10.3390/pharmaceutics14061125] [Reference Citation Analysis]
11 Madamsetty VS, Mohammadinejad R, Uzieliene I, Nabavi N, Dehshahri A, García-Couce J, Tavakol S, Moghassemi S, Dadashzadeh A, Makvandi P, Pardakhty A, Aghaei Afshar A, Seyfoddin A. Dexamethasone: Insights into Pharmacological Aspects, Therapeutic Mechanisms, and Delivery Systems. ACS Biomater Sci Eng 2022;8:1763-90. [PMID: 35439408 DOI: 10.1021/acsbiomaterials.2c00026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Naziris N, Demetzos C. Lipid Nanoparticles as Platforms for Theranostic Purposes: Recent Advances in the Field. JNT 2022;3:86-101. [DOI: 10.3390/jnt3020006] [Reference Citation Analysis]
13 Praveen TK, Gangadharappa HV, Abu Lila AS, Moin A, Mehmood K, Krishna KL, Hussain T, Alafanan A, Shakil S, Rizvi SMD. Inflammation targeted nanomedicines: patents and applications in cancer therapy. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.04.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Garg A, Garg R. Current advances in colloidal based delivery systems for Tacrolimus. Journal of Drug Delivery Science and Technology 2022;68:103108. [DOI: 10.1016/j.jddst.2022.103108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Mudigunda SV, Ravichandran G, Appidi T, Rengan AK. Ascorbic acid assisted synthesis of fluorescent PEG for bioimaging application. Materials Today: Proceedings 2022;62:5189-5193. [DOI: 10.1016/j.matpr.2022.02.630] [Reference Citation Analysis]
16 Peng S, Xiao F, Chen M, Gao H. Tumor-Microenvironment-Responsive Nanomedicine for Enhanced Cancer Immunotherapy. Adv Sci (Weinh) 2022;9:e2103836. [PMID: 34796689 DOI: 10.1002/advs.202103836] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 21.0] [Reference Citation Analysis]
17 Zhu W, Wei Z, Han C, Weng X. Nanomaterials as Promising Theranostic Tools in Nanomedicine and Their Applications in Clinical Disease Diagnosis and Treatment. Nanomaterials (Basel) 2021;11:3346. [PMID: 34947695 DOI: 10.3390/nano11123346] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
18 Ahmad J. Lipid Nanoparticles Based Cosmetics with Potential Application in Alleviating Skin Disorders. Cosmetics 2021;8:84. [DOI: 10.3390/cosmetics8030084] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
19 Sguizzato M, Esposito E, Cortesi R. Lipid-Based Nanosystems as a Tool to Overcome Skin Barrier. Int J Mol Sci 2021;22:8319. [PMID: 34361084 DOI: 10.3390/ijms22158319] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
20 Rizwanullah M, Ahmad MZ, Garg A, Ahmad J. Advancement in design of nanostructured lipid carriers for cancer targeting and theranostic application. Biochim Biophys Acta Gen Subj 2021;1865:129936. [PMID: 34058266 DOI: 10.1016/j.bbagen.2021.129936] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]